Intracavitary and Systemic Daptomycin for Successful Treatment of a Postpneumonectomy Intrathoracic Infection-Reference-Cited by-同舟云学术

Intracavitary and Systemic Daptomycin for Successful Treatment of a Postpneumonectomy Intrathoracic Infection

Published:2017-11 Issue:11 Volume:61 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Sangro Paloma¹,Carmona-Torre Francisco¹²,Mesa Miguel³,Del Pozo Jose L.²⁴,Yuste Jose R.¹²^ORCID

Affiliation:

1. Department of Internal Medicine, Clínica Universidad de Navarra, Pamplona, Spain

2. Division of Infectious Diseases, Clínica Universidad de Navarra, Pamplona, Spain

3. Department of Thoracic Surgery, Clínica Universidad de Navarra, Pamplona, Spain

4. Department of Clinical Microbiology, Clínica Universidad de Navarra, Pamplona, Spain

Abstract

ABSTRACT Treatment of an infected postpneumonectomy cavity is very difficult. We present a patient with an infection of a postpneumonectomy cavity by Staphylococcus epidermidis treated with local daptomycin for different dwell times, maintaining high antibiotic levels above the MIC. Clinical and microbiological cure were achieved successfully.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01330-17

Reference9 articles.

1. Causes and management of postpneumonectomy empyemas: our experience

2. Increased Killing of Staphylococci and Streptococciby Daptomycin Compared with Cefazolin and Vancomycin in an InVitro Peritoneal DialysateModel

3. Daptomycin: Another Novel Agent for Treating Infections Due to Drug‐Resistant Gram‐Positive Pathogens

4. Daptomycin: a novel cyclic lipopeptide antimicrobial;Schriever CA;Am J Health Syst Pharm,2005

5. Successful Use of Intraperitoneal Daptomycin in the Treatment of Vancomycin-Resistant Enterococcus Peritonitis